Marshall Wace, LLP Essa Pharma Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Essa Pharma Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 181,217 shares of EPIX stock, worth $284,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,217Holding current value
$284,510% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding EPIX
# of Institutions
47Shares Held
31MCall Options Held
24.1KPut Options Held
15.1K-
Bvf Inc San Francisco, CA8.75MShares$13.7 Million0.59% of portfolio
-
Tang Capital Management LLC San Diego, CA4.3MShares$6.75 Million0.58% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4.22MShares$6.63 Million4.69% of portfolio
-
Morgan Stanley New York, NY4.2MShares$6.59 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.26MShares$3.55 Million0.28% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $69.2M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...